Oryon Cell Therapies

Belmont, United States

Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses.

$21.0M raised

Mar 2026

Series A

Biotechnology

Top Investors

Neuro.VC Byers Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Oryon Cell Therapies

How much funding has Oryon Cell Therapies raised?

Oryon Cell Therapies has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.

Who are Oryon Cell Therapies's investors?

Oryon Cell Therapies's investors include Neuro.VC, Byers Capital.

Where is Oryon Cell Therapies headquartered?

Oryon Cell Therapies is headquartered in Belmont, United States.

What does Oryon Cell Therapies do?

Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses.

What stage is Oryon Cell Therapies at?

Oryon Cell Therapies is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 23, 2026.

MLA

"Oryon Cell Therapies — Funding & Investors." VCBacked, March 23, 2026, https://www.vcbacked.co/company/oryon-cell-therapies. Accessed July 2, 2026.

APA

VCBacked. (2026). Oryon Cell Therapies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oryon-cell-therapies

Wikipedia (cite web)

{{cite web |title=Oryon Cell Therapies — Funding & Investors |url=https://www.vcbacked.co/company/oryon-cell-therapies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 23, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K